Home Search
cannabinoids - search results
If you're not happy with the results, please do another search
IP protection in fast-moving global markets: Medical cannabis & CBD
Laura Clews, Managing Associate at IP attorneys Mathys & Squire, analyses the protection for innovative new products in the medical cannabis & CBD sector.
From Cannabis flower to final products: Extractions for Phytopharmaceuticals
Dr Nikos Xynos, PhD in Pharmaceutical Sciences/Natural Products Chemistry and MD a Nomad Labs, explores the various pathways to cannabinoid extraction, refining and purification technologies.
The importance of cannabinoid CBDa (cannabidiolic acid)
Katharina Zedlacher, PR and communications at BioBloom GmbH, details the recent studies conducted to highlight how cannabinoid CBDa (cannabidiolic acid) increases bioavailability of CBD and its health-promoting properties.
Closing gaps in cannabinoid research to make progress in pain management
David Shurtleff, PhD, Deputy Director at the National Center for Complementary and Integrative Health, National Institutes of Health (NIH), shares his thoughts on closing gaps in cannabinoid research to make progress in pain management.
Jersey Hemp granted CBD cultivation licence
Jersey Hemp share that they have been granted the first licence in the British Isles to harvest hemp flowers for CBD, in this article.
Can CBD be used to treat multiple sclerosis (MS)?
Content Marketing Specialist, Tammy Taylor details how CBD can be used to treat multiple sclerosis (MS) in this article.
The most common questions about CBD – Answered
Here, Keeley Berry, Nutritional Expert and Product Developer at BetterYou, answers the most commonly asked questions about CBD.
CBD market value expected to be almost £1 billion by 2025
Recent research commissioned by the Centre for Medicinal Cannabis has revealed that the UK CBD market is worth £300 million.
Cannabinoid supplements and medicines
Here, GreenLight Medicines tell us what they do and the excellent supplements and medicines they offer in connection with cannabinoids and health. We also learn about their excellent research and development of safe and effective plant-based medicines.
The future for hemp: What is at stake?
Lorenza Romanese, Managing Director of the European Industrial Hemp Association (EIHA) examines the future of hemp and explains in this vein, what is at stake, as well as looking back at its fascinating history.
CBD by the numbers: Exciting new products on the market
John Wallace, Managing Director of Mile High Labs, International, shares with us why CBD continues to be one of the most exciting new products to hit the marketplace and focuses here on some significant numbers in the field.
Reviving the hemp market in the Central Asian steppes
Hemp Mongolia LLC reveals its implementation plan to build the largest hemp processing farm in the Central Asian steppes.
So, you want to start a CBD brand?
Liam McGreevy and Elliott Findon from Ethnopharm Ltd highlight the key factors businesses must consider in order to set up a successful CBD brand.
Can CBD help aid mental health issues?
CBD has been gaining popularity over recent years, with a wide range of CBD infused products available to buy on the high street, but what is it, and can it really help?.
MariPharm: The world’s first medicinal cannabis company
Here, General Manager Bart den Hertog, introduces MariPharm, the world’s first medicinal cannabis business, highlighting the company’s major milestone moments, its clinical trial process and recommended product dosage.
Organic hemp producer BioBloom: “Health is our main focus”
BioBloom has specialised in the production of high-quality organic hemp products with absolutely no additives since 2016. The production focuses on the preservation of all valuable ingredients of the hemp plant.
Gregory Land – Canna CBD
Gregory Land Chief Executive Officer at Canna CBD.
Industrial hemp: Part of the cannabis sativa family
Henri Sant-Cassia from CBD Virtue turns the spotlight onto industrial hemp, a part of the cannabis sativa family.
Regulation and quality control for the medical cannabis industry
AlphaCAT (Cannabinoid Analysis Test) takes the first step to regulation and quality control for the medical cannabis industry, as this profile by the firm’s Sebastien Beguerie sheds light on.
Europe setting standards for cannabis products
As government authorities come to grips with legislation of cannabis-based products, the European market holds a key position, Liam McGreevy, CEO, Ethnopharm Ltd explains.
